Interestingly, CD40 has been reported as playing a role in B-ALL [59,73], with recent work in a patient-derived xenograft mouse model showing that a CD40 agonist could effectively target B-ALL cells [74]. Here, CD40 is linked to acute lymphoblastic leukemia.